- 16/04/2026Contexto:Sabe-se que a tuberculose pulmonar (TBP) ativa causa mudanças qualitativas e quantitativas no perfil imunológico sistêmico, resultando em um desequilíbrio…
- 16/04/2026Contexto:A tuberculose (TB) é uma doença inflamatória crônica com apresentações clínicas muito diversas. Embora cause enorme morbidade mundial, os determinantes…
- 16/04/2026Background:Since its discovery in 1947, the Zika virus (ZIKV) was responsible for sporadic and mild cases limited to Africa and…
- 16/04/2026Background:Tuberculosis (TB) is the leading cause of death in people living with HIV. While antitubercular treatment (ATT) is generally effective,…
- 15/04/2026Background:In high-burden settings, case fatality rates are reported to be between 11% and 32% in hospitalized patients with HIV-associated tuberculosis,…
- 15/04/2026Background:Diabetes mellitus (DM) significantly increases the risk of developing active pulmonary tuberculosis (TB) and experiencing adverse treatment outcomes, such as…
- 15/04/2026Background:Tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) represents a significant challenge in managing HIV-TB patients starting antiretroviral therapy (ART). It occurs…
- 15/04/2026Background:Active pulmonary tuberculosis (PTB) is known to cause qualitative and quantitative changes in the systemic immune profile, resulting in a…
- 15/04/2026Background:Tuberculosis (TB) is a chronic inflammatory disease with highly diverse clinical presentations. While it causes tremendous morbidity worldwide, the determinants…
- 15/04/2026ResumoObjetivo: descrever as expansões temporal e geográfica da circulação do vírus Zika (ZIKV) em países e territórios, desde seu isolamento…